Adult Attention Deficit/Hyperactivity Disorder, Associated Symptoms and Comorbid Psychiatric Disorders: Diagnosis and Pharmacological Treatment

被引:3
|
作者
Paslakis, G. [1 ]
Schredl, M. [1 ]
Alm, B. [1 ]
Sobanski, E. [1 ]
机构
[1] Heidelberg Univ, Klin Psychiat & Psychotherapie, Med Fak Mannheim, Zentralinst Seel Gesundheit, D-68159 Mannheim, Germany
关键词
adult ADHD; depression; substance abuse disorder; anxiety disorder; sleep disorder; DEFICIT-HYPERACTIVITY DISORDER; DOUBLE-BLIND; CONTROLLED-TRIAL; DUAL DIAGNOSIS; SLEEP QUALITY; METHYLPHENIDATE; ADHD; STIMULANTS; COCAINE; PREVALENCE;
D O I
10.1055/s-0033-1335657
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Adult attention deficit/hyperactivity disorder (ADHD) is characterised by inattention and/or hyperactivity and impulsivity and is a frequent psychiatric disorder with childhood onset. In addition to core symptoms, patients often experience associated symptoms like emotional dysregulation or low self-esteem and suffer from comorbid disorders, particularly depressive episodes, substance abuse, anxiety or sleep disorders. It is recommended to include associated symptoms and comorbid psychiatric disorders in the diagnostic set-up and in the treatment plan. Comorbid psychiatric disorders should be addressed with disorder-specific therapies while associated symptoms also often improve with treatment of the ADHD core symptoms. The most impairing psychiatric disorder should be treated first. This review presents recommendations for differential diagnosis and treatment of adult ADHD with associated symptoms and comorbid psychiatric disorders with respect to internationally published guidelines, clinical trials and expert opinions.
引用
收藏
页码:444 / 451
页数:8
相关论文
共 50 条
  • [31] Attention Deficit and Hyperactivity Disorder: Controversies of Diagnosis and Safety of Pharmacological and Nonpharmacological Treatment
    Benner-Davis, Shannon
    Heaton, Pamela C.
    CURRENT DRUG SAFETY, 2007, 2 (01) : 33 - 42
  • [32] Pharmacological treatment in adults with attention deficit hyperactivity disorder
    Frölich, J
    Lehmkuhl, G
    NERVENARZT, 2004, 75 (11): : 1074 - +
  • [33] PHARMACOLOGICAL TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    GREENHILL, LL
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 1992, 15 (01) : 1 - 27
  • [34] Pharmacological treatment for attention deficit hyperactivity disorder in adults
    Kweon, Kukju
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (01): : 49 - 56
  • [35] Psychiatric comorbid patterns in adults with attention-deficit hyperactivity disorder: Treatment effect and subtypes
    Tsai, Fang-Ju
    Tseng, Wan-Ling
    Yang, Li-Kuang
    Gau, Susan Shur-Fen
    PLOS ONE, 2019, 14 (02):
  • [36] The treatment of attention deficit hyperactivity disorder with comorbid tic hyperkinesis
    Chutko, L. S.
    Surushkina, S. W.
    Nikishena, I. S.
    Yakovenko, E. A.
    Lapshina, O. V.
    Anisimova, T. I.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2008, 108 (02): : 66 - 68
  • [37] Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder
    Lee, Jung Sup
    Myung, Ok Sun
    KOREAN JOURNAL OF FAMILY MEDICINE, 2008, 29 (01): : 1 - 12
  • [38] Clinical Response to Methylphenidate in Children Diagnosed With Attention-Deficit Hyperactivity Disorder and Comorbid Psychiatric Disorders
    Ter-Stepanian, Mariam
    Grizenko, Natalie
    Zappitelli, Michael
    Joober, Ridha
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2010, 55 (05): : 305 - 312
  • [39] Prevalence rates of comorbid disorders in attention deficit hyperactivity disorder adults
    Burke, Alban
    Vorster, Adri
    SOUTH AFRICAN JOURNAL OF PSYCHOLOGY, 2016, 46 (02) : 244 - 253
  • [40] Attention deficit hyperactivity disorder with comorbid anxiety disorders: pharmacotherapy options
    Zavadenko, N. N.
    Solomasova, A. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2012, 112 (08) : 44 - 48